These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 19255193

  • 1. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
    Lu YJ, Forte S, Thompson CM, Anderson PW, Malley R.
    Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
    [Abstract] [Full Text] [Related]

  • 2. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J, Sun T, Wang D, Dong Y, Xu M, Hou H, Kong FT, Liang C, Gu T, Chen P, Sun S, Lv X, Jiang C, Kong W, Wu Y.
    Immunol Invest; 2015 May; 44(5):482-96. PubMed ID: 26107747
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.
    Lu YJ, Yadav P, Clements JD, Forte S, Srivastava A, Thompson CM, Seid R, Look J, Alderson M, Tate A, Maisonneuve JF, Robertson G, Anderson PW, Malley R.
    Clin Vaccine Immunol; 2010 Jun; 17(6):1005-12. PubMed ID: 20427625
    [Abstract] [Full Text] [Related]

  • 5. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X, Li B, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Zhang Y, Wu Y.
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [Abstract] [Full Text] [Related]

  • 6. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH, Dai WJ, Chen B, Fan XY.
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [Abstract] [Full Text] [Related]

  • 7. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.
    Malley R, Srivastava A, Lipsitch M, Thompson CM, Watkins C, Tzianabos A, Anderson PW.
    Infect Immun; 2006 Apr; 74(4):2187-95. PubMed ID: 16552049
    [Abstract] [Full Text] [Related]

  • 8. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT, Xu Q, Paton JC, Hollingshead SK, Pichichero ME, Briles DE, Girgis N, Zeng M.
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
    [Abstract] [Full Text] [Related]

  • 9. A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.
    Lu YJ, Zhang F, Sayeed S, Thompson CM, Szu S, Anderson PW, Malley R.
    Vaccine; 2012 May 14; 30(23):3405-12. PubMed ID: 22465750
    [Abstract] [Full Text] [Related]

  • 10. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J, Dai W, Wang Z, Chen B, Li Z, Fan X.
    Clin Vaccine Immunol; 2011 Jan 14; 18(1):75-81. PubMed ID: 21047997
    [Abstract] [Full Text] [Related]

  • 11. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.
    Xu X, Meng J, Wang Y, Zheng J, Wu K, Zhang X, Yin Y, Zhang Q.
    J Microbiol; 2014 Apr 14; 52(4):315-23. PubMed ID: 24682994
    [Abstract] [Full Text] [Related]

  • 12. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
    Laiño J, Villena J, Suvorov A, Zelaya H, Ortiz Moyano R, Salva S, Alvarez S.
    PLoS One; 2018 Apr 14; 13(11):e0206661. PubMed ID: 30395582
    [Abstract] [Full Text] [Related]

  • 13. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
    Jakobsen H, Schulz D, Pizza M, Rappuoli R, Jónsdóttir I.
    Infect Immun; 1999 Nov 14; 67(11):5892-7. PubMed ID: 10531245
    [Abstract] [Full Text] [Related]

  • 14. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE, Hollingshead SK, Nabors GS, Paton JC, Brooks-Walter A.
    Vaccine; 2000 Dec 08; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [Abstract] [Full Text] [Related]

  • 15. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.
    Jakobsen H, Saeland E, Gizurarson S, Schulz D, Jónsdóttir I.
    Infect Immun; 1999 Aug 08; 67(8):4128-33. PubMed ID: 10417183
    [Abstract] [Full Text] [Related]

  • 16. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
    Pimenta FC, Miyaji EN, Arêas AP, Oliveira ML, de Andrade AL, Ho PL, Hollingshead SK, Leite LC.
    Infect Immun; 2006 Aug 08; 74(8):4939-44. PubMed ID: 16861686
    [Abstract] [Full Text] [Related]

  • 17. Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A.
    Liu Y, Wang H, Zhang S, Zeng L, Xu X, Wu K, Wang W, Yin N, Song Z, Zhang X, Yin Y.
    Infect Immun; 2014 Apr 08; 82(4):1666-75. PubMed ID: 24491576
    [Abstract] [Full Text] [Related]

  • 18. Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses.
    Pope C, Oliver EH, Ma J, Langton Hewer C, Mitchell TJ, Finn A.
    Vaccine; 2015 Mar 30; 33(14):1711-8. PubMed ID: 25698489
    [Abstract] [Full Text] [Related]

  • 19. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA, Converso TR, Gonçalves VM, Leite LCC, Tanizaki MM, Barazzone GC.
    Clin Vaccine Immunol; 2017 Aug 30; 24(8):. PubMed ID: 28637805
    [Abstract] [Full Text] [Related]

  • 20. Protection against fatal pneumonia through mucosal and subcutaneous immunization with the pneumococcal SP0148 protein.
    Huang J, Luo S, Huang M, Zhang T, Min Z, Liu C, Zhang Q, Yang J, Min X.
    Microb Pathog; 2019 Apr 30; 129():206-212. PubMed ID: 30772476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.